345 related articles for article (PubMed ID: 19141376)
1. Are renal reference intervals required when screening for plasma cell disorders with serum free light chains and serum protein electrophoresis?
Abadie JM; van Hoeven KH; Wells JM
Am J Clin Pathol; 2009 Feb; 131(2):166-71. PubMed ID: 19141376
[TBL] [Abstract][Full Text] [Related]
2. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA
Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305
[TBL] [Abstract][Full Text] [Related]
3. Assessment of serum free light chain assays for plasma cell disorder screening in a Veterans Affairs population.
Abadie JM; Bankson DD
Ann Clin Lab Sci; 2006; 36(2):157-62. PubMed ID: 16682511
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
5. [Detection of serum free light chain and its clinical significance in nonsecretory multiple myeloma].
Chen HF; Hou J; Yuan ZG; Wang DX; Fu WJ; Chen YB
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):113-6. PubMed ID: 18681313
[TBL] [Abstract][Full Text] [Related]
6. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880
[TBL] [Abstract][Full Text] [Related]
8. Serum free light chain assay reduces the need for serum and urine immunofixation electrophoresis in the evaluation of monoclonal gammopathy.
Fulton RB; Fernando SL
Ann Clin Biochem; 2009 Sep; 46(Pt 5):407-12. PubMed ID: 19641008
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of serum free light chains in renal transplantation.
Sánchez-Castañón M; Gago M; Fernandez-Fresnedo G; Gomez-Alamillo C; Ruiz-Criado J; Lopez-Hoyos M; Arias M
Transplant Proc; 2010 Oct; 42(8):2861-3. PubMed ID: 20970552
[TBL] [Abstract][Full Text] [Related]
10. The association of serum-free light-chain levels with markers of renal function.
Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H
Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734
[TBL] [Abstract][Full Text] [Related]
11. Serum free light chain analysis may miss monoclonal light chains that urine immunofixation electrophoreses would detect.
Shaheen SP; Levinson SS
Clin Chim Acta; 2009 Aug; 406(1-2):162-6. PubMed ID: 19410572
[TBL] [Abstract][Full Text] [Related]
12. [Clinical usefulness of serum free light chain measurement in monoclonal gammopathy].
Shimazaki C; Murakami H; Sawamura M; Matsuda M; Kinoshita T; Hata H; Sugiura I; Tsushita K; Nagura E; Kosugi H; Itoh J; Shimizu K
Rinsho Ketsueki; 2010 Apr; 51(4):245-52. PubMed ID: 20467220
[TBL] [Abstract][Full Text] [Related]
13. Phenotyping polyclonal kappa and lambda light chain molecular mass distributions in patient serum using mass spectrometry.
Barnidge DR; Dasari S; Ramirez-Alvarado M; Fontan A; Willrich MA; Tschumper RC; Jelinek DF; Snyder MR; Dispenzieri A; Katzmann JA; Murray DL
J Proteome Res; 2014 Nov; 13(11):5198-205. PubMed ID: 25134970
[TBL] [Abstract][Full Text] [Related]
14. Serum immunoglobulin free light chain and heavy/light chain measurements in POEMS syndrome.
Wang C; Su W; Zhang W; Di Q; Duan MH; Ji W; Cao XX; Zhou DB; Li J
Ann Hematol; 2014 Jul; 93(7):1201-6. PubMed ID: 24482101
[TBL] [Abstract][Full Text] [Related]
15. Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia.
Pratt G; Harding S; Holder R; Fegan C; Pepper C; Oscier D; Gardiner A; Bradwell AR; Mead G
Br J Haematol; 2009 Jan; 144(2):217-22. PubMed ID: 19016722
[TBL] [Abstract][Full Text] [Related]
16. Fever of unknown origin (FUO) due to Rosai-Dorfman disease with mediastinal adenopathy mimicking lymphoma: diagnostic importance of elevated serum ferritin levels and polyclonal gammopathy.
Cunha BA; Durie N; Selbs E; Pherez F
Heart Lung; 2009; 38(1):83-8. PubMed ID: 19150534
[TBL] [Abstract][Full Text] [Related]
17. Light-chain removal by plasmapheresis in myeloma-associated renal failure.
Cserti C; Haspel R; Stowell C; Dzik W
Transfusion; 2007 Mar; 47(3):511-4. PubMed ID: 17319833
[TBL] [Abstract][Full Text] [Related]
18. Replacing urine protein electrophoresis with serum free light chain analysis as a first-line test for detecting plasma cell disorders offers increased diagnostic accuracy and potential health benefit to patients.
McTaggart MP; Lindsay J; Kearney EM
Am J Clin Pathol; 2013 Dec; 140(6):890-7. PubMed ID: 24225758
[TBL] [Abstract][Full Text] [Related]
19. Combined analysis using extended renal reference range of serum free light chain ratio and serum protein electrophoresis improves the diagnostic accuracy of multiple myeloma in renal insufficiency.
Park JW; Kim YK; Bae EH; Ma SK; Kim SW
Clin Biochem; 2012 Jul; 45(10-11):740-4. PubMed ID: 22503879
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
